Aimmune Therapeutics (AIMT) Confirms FDA Approves its PALFORZIA as First Treatment for Peanut Allergy
Go back to Aimmune Therapeutics (AIMT) Confirms FDA Approves its PALFORZIA as First Treatment for Peanut Allergy| AIMSI Technologies (NASDAQ: AIMT) | Delayed: 34.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.49 | 52 Week High | $27.31 | |||
| Open | $7.76 | 52 Week Low | $9.77 | |||
| Day High | $34.49 | P/E | N/A | |||
| Day Low | $34.49 | EPS | $0.00 | |||
| Volume | 42,896 | |||||
